Globus Medical (NYSE: GMED) has announced that it will be unveiling its third quarter financial results on Tuesday 5th November 2024. This announcement is set to occur after market close, allowing investors and analysts to gain valuable insights into the company's performance during the quarter.
It appears that the establishment is on the verge of revealing their estimated $0.65 profit per share for the quarter, as well as their total revenue of $603.93 million for this specific period, according to financial experts on Wall Street.
The company's earnings report from the corresponding quarter of the previous year demonstrated a per-share income of $0.57. Additionally, the company achieved a total revenue of $383.64 million during that specific period.
The projections from Wall Street analysts indicate that the company is expected to generate a total revenue of $2.48 billion for the full year. Moreover, they anticipate the earnings per share to reach profit of $2.85 during the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $0.75 | +19.0% | 629.69 M | +115.9% |
| Q1 2024 | $0.72 | +35.8% | 606.67 M | +119.3% |
| Q4 2023 | $0.60 | +1.7% | 616.53 M | +124.6% |
| Q3 2023 | $0.57 | +14.0% | 383.64 M | +51.0% |
| Q2 2023 | $0.63 | +12.5% | 291.62 M | +10.6% |
| *Growth on year-over-year basis | ||||
GMED will host a conference call with investment community on 5th November 2024 at 04:30 PM eastern time to discuss the financial results.
Friday's trading saw Globus Medical (GMED) shares hit a low of $73.31 and a high of $75.52, with a day volume of 686.20 thousand shares. The stock closed the regular trading session at $74.88, demonstrating 1.82 percent advance.
